tripelennamine has been researched along with Respiration Disorders in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itkonen, J | 1 |
| Schnoll, S | 1 |
| Daghestani, A | 1 |
| Glassroth, J | 1 |
1 other study available for tripelennamine and Respiration Disorders
| Article | Year |
|---|---|
Accelerated development of pulmonary complications due to illicit intravenous use of pentazocine and tripelennamine.
Topics: Adult; Exercise Test; Female; Heroin; Humans; Lung; Male; Pentazocine; Respiration Disorders; Substa | 1984 |